MedPrax is the HIPAA-grade, e-Rx-ready, white-label infrastructure that lets a licensed clinician run a fully-branded telehealth practice at yourname.medprax.ai. In days, not months. You stay the clinician. We're the stack.
Florida-first launch market · 14-day free trial or 20 consults, whichever first · no credit card
See the patient experience
MedPrax replicates the async-AI consult model now standard in modern cash-pay telehealth, on your domain. Your branding. Your clinical workflow. You make every decision.
Your domain, your brand, your conditions. Patients see a Maya Metabolic site, not a MedPrax site.
Conversational intake constrained to your decision tree. The AI clarifies and rephrases; it does not replace your clinical judgment.
Government-ID + selfie via AWS Rekognition. Done before the patient pays. Result + thumbnail surface in your queue.
Patient picks a pharmacy from the Photon directory. Pays via Stripe. Your fee — your bank account, minus our flat platform fee.
Structured intake + AI summary in your queue. The flow is designed for sub-5-minute review; e-Rx routes through Photon to the pharmacy the patient chose.
What comes in the box
Launch at yourname.medprax.ai on every plan. Custom domain (e.g. yourname.com) coming on Practice and Scale.
Each condition ships with a MedPrax-authored default intake tree (weight loss / GLP-1 at launch). You're the clinical author of record. Tenant-side tree customization arrives in Phase 1.
Bedrock-backed Claude Haiku 4.5 runs the patient conversation, constrained to your tree. Claude Sonnet 4.6 summarizes for your review.
Surescripts-connected e-Rx to any US pharmacy. v1 prescribes brand-only FDA-approved GLP-1s, routed to the patient's chosen pharmacy.
AWS Rekognition Face Liveness + Textract AnalyzeID + CompareFaces, in-house on the AWS BAA. No third-party identity vendor in your patient flow.
Patient pays in your checkout. Your consult fee lands in your bank account. We collect only our published platform fee.
Every state-changing action lands in S3 with Object Lock at a configurable retention window. Searchable via Athena.
Optional inbound demand from medprax.ai/find-a-doctor on a 25% rev share. Coming in Phase 1 — Phase 0 is bring-your-own-audience.
MedPrax provides the software, payment rails, and compliance posture. Every clinical decision is yours.
Pricing
Every plan includes the platform, BAA, AI consult engine, e-Rx, payouts, and HIPAA-grade infrastructure. Pay for the volume you actually run.
Validate the model and book your first 50 consults.
Built for real volume and your own brand.
Multi-provider practices and group infrastructure.
Payment processing: 3.5% + $0.30 per patient transaction, included in your patient's checkout. Your consult fee comes to you whole, less any per-consult overage when applicable.
Early access is hand-onboarded. 14-day free trial OR 20 consults, whichever comes first. No credit card.
The facilitator model
Compliance & risk
At onboarding we run your NPI through the public NPPES registry and match it to the name on your government ID (via our in-house Rekognition + Textract verification pipeline). We then verify your state license against each state's medical board. License verification is manual at launch; we're automating it through FSMB / VeriDoc.
MedPrax signs a Business Associate Agreement with your covered entity at onboarding. Our upstream covered service is AWS — every PHI-handling component (Lambda, DynamoDB, S3, Bedrock, Rekognition, Textract) is in scope. Photon Health signs its own BAA for e-Rx. Stripe does NOT sign BAAs — it processes payments under the HIPAA §1179 exemption, and we keep PHI out of all Stripe metadata to stay inside that exemption.
Yes for non-controlled prescriptions at launch. We route Surescripts-connected e-Rx via Photon Health to any US pharmacy. EPCS (controlled substances) is deferred — when we add it we'll meet DEA two-factor and biometric requirements. At launch we prescribe brand-only FDA-approved GLP-1s — no compounded products, no controlled substances.
Your tenant is suspended immediately. Active patients receive a system email directing them to seek care elsewhere; we provide their consult and prescription history on request. MedPrax does not transfer patients to other providers without their explicit consent.
Async telehealth prescribing is covered by most major medical malpractice carriers, but you must confirm with your underwriter before publishing. Your binder should explicitly include async telehealth. We'll share our platform security and HIPAA documentation with your carrier on request.
Upload a license for each state in your dashboard, and MedPrax handles state-availability routing, patient-side eligibility gating, and per-state pricing controls. Patients in unsupported states get a clear message — and, when the marketplace ships in Phase 1, the option to find another clinician.
Yes. You can export every patient consult, intake answer, and prescription record at any time. We provide a full data export bundle on offboarding within 30 days. The PHI itself was always your covered-entity record — we held it as your business associate.
As of April 30, 2026 the FDA proposed excluding semaglutide, tirzepatide, and liraglutide from the 503B Bulks List and has been actively pushing back on the differentiation workaround that most telehealth platforms use. Starting brand-only is the defensible, low-regulatory-risk posture. We'll re-evaluate compounded with legal infrastructure and pharmacy partnerships when the rules settle.
MedPrax is software infrastructure. We're not your employer. We don't make clinical decisions. We don't certify clinical quality. We don't stand between you and your patients. We provide the platform, the payment rails, and the compliance posture; you run your practice.
We handle the rails. You get back the part of practicing medicine you actually like.